Details for Patent: RE49826
✉ Email this page to a colleague
Which drugs does patent RE49826 protect, and when does it expire?
Patent RE49826 protects KERENDIA and is included in one NDA.
This patent has thirty-four patent family members in thirty countries.
Summary for Patent: RE49826
| Title: | Method for the preparation of (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient |
| Abstract: | The present invention related to a novel and improved process for preparing (4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide of the formula (I) |
| Inventor(s): | Johannes Platzek |
| Assignee: | Bayer Pharma AG |
| Application Number: | US17/367,066 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent RE49826 |
|
Patent Claim Types: see list of patent claims | Use; Compound; Process; |
Drugs Protected by US Patent RE49826
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Hlthcare | KERENDIA | finerenone | TABLET;ORAL | 215341-001 | Jul 9, 2021 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Bayer Hlthcare | KERENDIA | finerenone | TABLET;ORAL | 215341-002 | Jul 9, 2021 | RX | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| Bayer Hlthcare | KERENDIA | finerenone | TABLET;ORAL | 215341-003 | Jul 11, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent RE49826
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 105774 | ⤷ Start Trial | |||
| Australia | 2016312904 | ⤷ Start Trial | |||
| Canada | 2995905 | ⤷ Start Trial | |||
| Chile | 2018000427 | ⤷ Start Trial | |||
| China | 107849043 | ⤷ Start Trial | |||
| Colombia | 2018001466 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
